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Abstract: Contamination of food and feed with mycotoxins is a worldwide problem. At 
present, acute mycotoxicosis caused by high doses is rare in humans and animals. Ingestion 
of low to moderate amounts of Fusarium mycotoxins is common and generally does not 
result in obvious intoxication. However, these low amounts may impair intestinal health, 
immune function and/or pathogen fitness, resulting in altered host pathogen interactions and 
thus a different outcome of infection. This review summarizes the current state of 
knowledge about the impact of Fusarium mycotoxin exposure on human and animal host 
susceptibility to infectious diseases. On the one hand, exposure to deoxynivalenol and 
other Fusarium mycotoxins generally exacerbates infections with parasites, bacteria and 
viruses across a wide range of animal host species. Well-known examples include 
coccidiosis in poultry, salmonellosis in pigs and mice, colibacillosis in pigs, necrotic 
enteritis in poultry, enteric septicemia of catfish, swine respiratory disease, aspergillosis in 
poultry and rabbits, reovirus infection in mice and Porcine Reproductive and Respiratory 
Syndrome Virus infection in pigs. However, on the other hand, T-2 toxin has been shown 
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to markedly decrease the colonization capacity of Salmonella in the pig intestine. Although 
the impact of the exposure of humans to Fusarium toxins on infectious diseases is less well 
known, extrapolation from animal models suggests possible exacerbation of, for instance, 
colibacillosis and salmonellosis in humans, as well. 
Keywords: deoxynivalenol; fumonisin; Fusarium mycotoxins; human; infectious diseases; 
mouse; pig; poultry; T-2 toxin; zearalenone 
 
1. Introduction 
Mycotoxins are toxic fungal metabolites that can contaminate a wide array of food and feed [1]. 
Mycotoxin-producing fungi can be classified into either field or storage fungi. Field fungi, such as the 
Fusarium species, produce mycotoxins on the crops in the field, whereas storage fungi, such as the 
Aspergillus and Penicillium species, produce mycotoxins on the crops after harvesting [2]. Fusarium 
fungi have traditionally been associated with temperate climatic conditions, since they require 
somewhat lower temperature for growth and mycotoxin production than, for example, the Aspergillus 
species [3]. The most toxicologically important Fusarium mycotoxins are trichothecenes (including 
deoxynivalenol (DON) and T-2 toxin (T-2)), zearalenone (ZEN) and fumonisin B1 (FB1). 
Fusarium mycotoxins are capable of inducing both acute and chronic toxic effects. These effects 
are dependent on the mycotoxin type, the level and duration of exposure, the animal species that is 
exposed and the age of the animal [4]. Intake of high doses of mycotoxins may lead to acute 
mycotoxicoses, which are characterized by well-described clinical signs [5,6]. Exposure of pigs to high 
concentrations of DON causes abdominal distress, malaise, diarrhea, emesis and even shock or death. 
Exposure of pigs to fumonisins can lead to pulmonary edema due to cardiac insufficiency. In horses 
fumonisins can cause equine leukoencephalomalacia (ELEM) and target the brain [7]. Since these high 
contamination levels are rare in modern agricultural practice [8], this review will not discuss 
extensively their effect on animal or human health. Indeed, although the results of a global survey 
indicate that the Fusarium mycotoxins DON, fumonisins, and ZEN respectively contaminated 55%, 
54% and 36% of feed and feed ingredients in the period 2004–2011, the majority of samples was 
found to comply with even the most stringent European Union regulations or recommendations on the 
maximal tolerable concentration (Table A3) [8]. Therefore, this review will focus on the effect of low 
to moderate doses of the major Fusarium mycotoxins. 
Following oral intake of low to moderate amounts of these mycotoxins, the gastro-intestinal 
epithelial cell layer will be exposed first [9]. The intestinal mucosa acts as a barrier, preventing the 
entry of foreign antigens including food proteins, xenobiotics (such as drugs and toxins), commensal 
microbiota and pathogens into the underlying tissues [9,10]. The mucosal immunity, which consists of 
an innate and adaptive immune system, can be affected by Fusarium mycotoxins (Figure 1) [9,10]. An 
important component of the innate immune system are the intestinal epithelial cells, which are 
interconnected by tight junctions, and covered with mucus, produced by goblet cells [11]. By measuring 
the transepithelial electrical resistance (TEER), several in vitro and ex vivo studies indicate that DON 
and FB1 are able to increase the permeability of the intestinal epithelial layer of human, porcine and 
avian origin [12–14]. Also the viability and proliferation of animal and human intestinal epithelial cells 
can be negatively affected by Fusarium mycotoxins [9,15–20]. Their effect on mucus production is 
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variable: co-exposure of low doses of DON, T-2 and ZEN reduces the number of goblet cells in pigs [21], 
but ZEN given alone at higher doses increases the activity of goblet cells [22]. Several mycotoxins are 
also able to modulate the production of cytokines in vitro and in vivo [9,23]. For example, DON 
increases the expression of TGF-β and IFN-γ in mice and fumonisins decrease the expression of IL-8 
in an intestinal porcine epithelial cell line (IPEC-1) [9]. 
Figure 1. The effect of Fusarium mycotoxins on the intestinal epithelium. A variety of 
Fusarium mycotoxins alter the different intestinal defense mechanisms including epithelial 
integrity, cell proliferation, mucus layer, immunoglobulins (Ig) and cytokine production. 
(IEC: intestinal epithelial cell) (based on [9]). 
 
Fusarium mycotoxins can cross the intestinal epithelium and reach the systemic compartment [20,24], 
affecting the immune system. Exposure to these toxins can either result in immunostimulatory or 
immunosuppressive effects depending on the age of the host and exposure dose and duration [20,25]. 
Mycotoxin-induced immunomodulation may affect innate and adaptive immunity by an impaired 
function of macrophages and neutrophils, a decreased T- and B-lymphocyte activity and antibody 
production [23,25,26]. In addition to the effect of Fusarium mycotoxins on the animal or human host, 
these mycotoxins may alter the metabolism of the pathogen, which may alter the outcome of the 
infectious disease [27,28]. 
A wealth of research papers clearly indicate a negative influence of Fusarium mycotoxins on the 
intestinal function and immune system. Since the intestinal tract is also a major portal of entry to many 
enteric pathogens and their toxins, mycotoxin exposure could increase the animal susceptibility to 
these pathogens. Furthermore, mycotoxin-induced immunosuppression may also result in decreased 
animal or human host resistance to infectious diseases. 
This review attempts to summarize the impact of Fusarium mycotoxin exposure on the animal and 
human host susceptibility to infectious diseases. More specifically, the effect of Fusarium mycotoxins 
on enteric, systemic and respiratory infectious diseases in livestock animals and animal models for 
human diseases are highlighted. 
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2. Effect of Fusarium Toxins on Parasitic Diseases 
Coccidiosis 
Intestinal protozoa, including the coccidia (Eimeria, Isospora, Cryptosporidium and Sarcosporidia) 
and flagellates, are important infectious agents. Coccidiosis in poultry generally refers to the disease 
caused by the Eimeria species, and is still considered one of the most important enteric diseases 
affecting performance. These obligate intracellular parasites have an oral-fecal life cycle with 
developmental stages alternating between the external environment and the host [29]. 
Seven species of Eimeria (E. acervulina, E. brunetti, E. maxima, E. mitis, E. necatrix, E. praecox 
and E. tenella) are found in chickens [29]. The physical and biological characteristics, pathogenicity 
and immunogenicity depend on the species. Immunity to Eimeria is complex, multifactorial and 
influenced by both host and parasite [30]. 
Cell-mediated immunity, mainly evoked by the intraepithelial lymphocytes (IEL) and lymphocytes 
of the lamina propria, is the major protective immune component against avian coccidiosis [31,32]. 
The CD4+ T-lymphocytes, IEL and macrophages are involved in the response against primary 
exposure to Eimeria [31], while CD8+ T-lymphocytes and IFN-γ are important in the protective 
immune response against Eimeria infection [33]. Girgis et al. [34,35] showed a negative impact of 
diets naturally contaminated with Fusarium mycotoxins on the cell-mediated immune response against 
coccidiosis in broilers (Table A2). Following primary infection of broilers with Eimeria, Fusarium 
mycotoxins decreased the percentage of CD4+ and CD8+ T-cells in the jejunal mucosa [35]. In addition, 
feeding on a mycotoxin-contaminated diet lowered the blood levels of CD8+ T-cells and monocytes, 
which could suggest an increased recruitment at the intestinal site of coccidial infection or a delayed 
replication necessary to replenish these subsets in the circulation [34,35]. Additionally, feeding on a 
Fusarium mycotoxin-contaminated diet increased IFN-γ gene expression in the cecal tonsils of 
Eimeria-challenged birds, however, without being linked to the apparent resistance to coccidial 
infection in terms of changes in oocyst yield [34]. The cecal tonsils constitute a lymphoid tissue in the 
cecum belonging to the gut-associated lymphoid tissue (GALT). Resistance to Eimeria infection is 
related to the expression of a set of interleukins rather than only IFN-γ and the up-regulation of the 
gene may not necessarily be associated with functional secretion [34]. Furthermore, it was shown that 
moderate levels of Fusarium mycotoxins negatively affect intestinal morphology and interfere with 
intestinal recovery from an enteric coccidial infection, indicated by a lower villus height and apparent 
villus area (Table A2) [36]. Although Girgis et al. [34,35] demonstrated that Fusarium mycotoxins 
impair the Eimeria-induced immune response, no effect was seen on fecal oocyst counts. Similarly, 
Békési et al. [37] showed no impact of a T-2 and ZEN-contaminated diet on Cryptosporidium baileyi 
oocyst excretion in broilers. 
Research investigating the influence of mycotoxins on the animal susceptibility to infectious 
diseases focuses mainly on exposure to single major mycotoxins. Limited information about the impact 
of mycotoxin co-occurrence and plant metabolites of mycotoxins on this interaction is available. 
Nevertheless, Girgis et al. [34,35] showed that the combination of DON, 15-acetylDON (15-AcDON), 
ZEN and fumonisins alters the Eimeria-induced immune response. Interestingly, mycotoxin 
contamination of broiler feed may reduce the efficacy of the anti-coccidial treatment with lasalocid [38]. 
To conclude, Fusarium mycotoxins negatively affect the innate and adaptive cellular immune 
response against Eimeria, though without changing the oocyst yield. Further data of clinical coccidiosis 
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lesion scoring is still needed in order to evaluate the effect of Fusarium mycotoxins on the severity of 
the disease. 
3. Effect of Fusarium Toxins on Bacterial Diseases 
3.1. Salmonellosis 
Salmonellosis is an infection with the Gram-negative Salmonella bacterium, a facultative anaerobic, 
facultative intracellular microorganism of the Enterobacteriaceae family. The host—Salmonella 
interaction is complex, with a broad array of mechanisms used by the bacteria to overcome host 
defenses. Two important disease manifestations are differentiated, i.e., gastroenteritis and enteric fever, 
caused by nontyphoidal and typhoidal Salmonella serovars, respectively [39]. 
Nontyphoidal Salmonella strains, such as Salmonella serovar Typhimurium and Salmonella serovar 
Enteritidis strains, infect a wide range of animal hosts, including pigs and poultry, without causing 
clinical symptoms in these animals. Infection in slaughter pigs and poultry can cause meat and egg 
contamination [39,40]. 
An infection with Salmonella generally occurs in three stages: the adhesion to the intestinal wall, 
the invasion of the gut wall and the dissemination to mesenteric lymph nodes and other organs. Via 
bacterial-mediated endocytosis, Salmonella invades the intestinal epithelial cells, after which the 
bacterium becomes enclosed within an intracellular phagosomal compartment (the Salmonella-containing 
vacuole (SCV)). After crossing the epithelial barrier, the bacterium is located predominantly in 
macrophages in the underlying tissue [39]. 
Feeding pigs a Fusarium mycotoxin-contaminated diet influences the intestinal phase of the 
pathogenesis of Salmonella Typhimurium infections as illustrated in Figure 2. Non-cytotoxic 
concentrations of DON and T-2 enhance intestinal Salmonella invasion and increase the passage of 
Salmonella Typhimurium across the epithelium (Table A1) [28,41]. Chronic exposure of specific 
pathogen-free pigs to naturally fumonisin-contaminated feed had no impact on Salmonella Typhimurium 
translocation [42]. Once Salmonella has invaded the intestinal epithelium, the innate immune system is 
triggered and the porcine gut will start to produce several cytokines [28,43]. Both Fusarium 
mycotoxins and Salmonella affect the innate immune system. Vandenbroucke et al. [27] showed that 
low concentrations of DON could potentiate the early intestinal immune response induced by 
Salmonella Typhimurium infection. Co-exposure of the intestine to DON and Salmonella Typhimurium 
resulted in increased expression of several cytokines, for instance, those responsible for the stimulation 
of the inflammatory response (TNF-α) and T-lymphocyte stimulation (IL-12) (Table A2). The authors 
suggested that the enhanced intestinal inflammation could be due to a DON-induced stimulation of 
Salmonella Typhimurium invasion in and translocation across the intestinal epithelium [27]. 
Fusarium mycotoxins also affect the systemic part of the Salmonella Typhimurium infection in 
pigs. After the intestinal phase of the pathogenesis, Salmonella can spread to the bloodstream using the 
host macrophage to establish the systemic infection. However, in pigs the systemic part of Salmonella 
Typhimurium is poorly documented and colonization is mostly limited to the gastrointestinal tract [44]. 
After bacterial uptake by the macrophage, Salmonella can survive and even proliferate in this cell. 
Exposure of macrophages to non-cytotoxic concentrations of DON and T-2 promotes the uptake of 
Salmonella Typhimurium (Figure 2, Table A1). Salmonella entry in host cells involves a complex 
series of actin cytoskeletal changes. Macrophage invasion coincides with membrane ruffling, followed 
by bacterium uptake and formation of Salmonella-containing vacuole [41]. Vandenbroucke et al. [41] 
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showed in vitro that DON enhances Salmonella Typhimurium engulfment, since low concentrations of 
DON modulate the cytoskeleton of macrophages through ERK1/2 F-actin reorganization resulting in 
an enhanced uptake of Salmonella Typhimurium in porcine alveolar macrophages (PAM) (Figure 2, 
Table A1). Non-cytotoxic concentrations of the Fusarium mycotoxins DON and T-2 did not affect the 
intracellular proliferation of Salmonella Typhimurium in porcine macrophages (Figure 2) [28,41]. 
Figure 2. The impact of deoxynivalenol and T-2 toxin on a Salmonella Typhimurium 
infection in pigs. In vitro, deoxynivalenol (DON) and T-2 toxin (T-2) promote Salmonella 
invasion (1) and transepithelial passage (2) of IPEC-J2 cell layer. Subsequently, the 
bacterium can spread to the bloodstream using the host macrophage to establish the 
systemic infection. In vitro, DON and T-2 enhance Salmonella uptake (3) in porcine 
alveolar macrophages. The Salmonella invasion of macrophages coincides with membrane 
ruffling, caused by actin cytoskeletal changes. Activation of host Rho GTPases by the 
Salmonella pathogenicity island (SPI)-1 type 3 secretion system (T3SS) effector proteins 
SopB, SopE, SopE2 and SopD leads to actin cytoskeleton reorganization. After Salmonella 
internalization has occurred, the bacterium injects the effector protein SptP which promotes 
the inactivation of Rho GTPases. The bacterium can also modulate the actin dynamics of 
the host cell in a direct manner through the bacterial effector proteins SipA and SipC. The 
mycotoxin DON enhances the uptake of Salmonella in macrophages through activation of 
the mitogen-activated protein kinases (MAPK) extracellular signal-regulated kinases 
(ERK1/2) pathway, which induces actin reorganizations and membrane ruffles. DON and 
T-2 do not affect intracellular bacterial proliferation (4) (based on [41,44]). 
 
In addition to the effects of Fusarium mycotoxins on the host susceptibility to a Salmonella 
Typhimurium infection, these mycotoxins also modulate the bacterial metabolism. Although no effect 
of DON or T-2 on the growth of Salmonella Typhimurium is detected, DON and T-2 modulate the 
Salmonella gene expression [28,41]. The enhanced inflammatory effect following exposure to DON is 
more likely a result of the toxic effect of the mycotoxin on the intestine than on the bacterium [27]. 
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Only high concentrations of DON increase the bacterial expression of regulators of Salmonella 
pathogenicity island (SPI)-1 and SPI-2, respectively hilA and ssrA. SPI-1 consists of genes coding for 
bacterial secretion systems necessary for invasion, while SPI-2 genes encode essential intracellular 
replication mechanisms [41]. For T-2 the toxic effects on the bacterium itself are probably more 
pronounced than the host cell-mediated effects resulting in a reduced in vivo colonization in pigs. Low 
concentrations of T-2 cause a reduced motility of Salmonella and a general down regulation of genes 
involved in Salmonella metabolism, genes encoding ribosomal proteins and SPI-1 genes [28]. 
Only limited information is available concerning the interaction between Fusarium mycotoxins and 
Salmonella Typhimurium infection in other animals. The currently available publications mainly focus 
on the interaction of T-2 and the systemic phase of a Salmonella Typhimurium infection. In  
T-2-challenged broiler chickens and mice an increased level of Salmonella Typhimurium-related organ 
lesions or mortality was seen (Table A2) [45–48]. Infection of mice with Salmonella Typhimurium 
results in systemic infection and a disease similar to that seen in humans after infection with 
Salmonella Typhi [49]. Increased mortality might be explained partly by the synergistic effects of 
bacterial lipopolysaccharide (LPS) and T-2 during the late phase of murine salmonellosis [50]. In 
addition to Salmonella Typhimurium, DON reduces the resistance to oral infection with Salmonella 
Enteritidis in mice by promoting translocation of Salmonella to mesenteric lymph node (MLN), liver 
and spleen (Table A2) [51]. 
Mouse and pig models are important animal models to investigate the impact of mycotoxins, 
infectious diseases and their combination on animal health [52,53]. Infection of mice with Salmonella 
Typhimurium is an important host–pathogen interaction model to investigate typhoid fever in humans. 
Moderate to high concentrations of T-2 have shown to increase Salmonella-induced mortality [46,47,50]. 
The pig is very similar to humans in terms of anatomic and physiologic characteristics such as size, 
digestive physiology, kidney structure and function, pulmonary vascular bed structure, coronary artery 
distribution, respiratory rates, cardiovascular anatomy and physiology, and immune response, and has 
been used to study various intestinal pathogens, including Salmonella and Escherichia coli [53]. The 
interaction between mycotoxins and Salmonella Typhimurium studied in a porcine model of infection, 
gives us relevant information concerning the impact of this interaction on human intestinal 
inflammation and immune response [27]. 
In conclusion, the exact outcome of co-exposure to Fusarium mycotoxins and Salmonella 
Typhimurium is difficult to predict. Published data show an influence of mycotoxin exposure on the 
bacterium, the host cells and the host–pathogen interaction. Depending on the characteristics of the 
mycotoxin exposure, one of these effects will determine the outcome of the interaction between 
Fusarium mycotoxins and Salmonella Typhimurium. 
3.2. Colibacillosis 
Escherichia coli is a Gram-negative, non-sporulating rod-shaped bacterium of the family 
Enterobacteriaceae. Although this bacterium is considered to be a normal component of the intestinal 
microbiota, it is frequently associated with both intestinal and extra-intestinal infections in humans and 
animals. A certain number of these strains possess particular combinations of virulence factors which 
enables them to cause disease. Clinical syndromes resulting from infection with these pathotypes 
include enteric/diarrheal disease, urinary tract infections and sepsis/meningitis. 
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The pathogenesis of E. coli infections depends on the pathotype involved and may include 
colonizing the intestinal mucosa, evasion of host defenses, multiplication, and induction of host 
damage [54,55]. 
Fusarium mycotoxins may influence the pathogenesis of E. coli infections in different animal 
species by stimulating intestinal colonization and translocation and negatively affecting the immune 
response. Feeding a diet contaminated with a moderate level of FB1 to pigs enhanced intestinal 
colonization and translocation of a septicemic E. coli (SEPEC) strain from the intestine to the systemic 
compartment. FB1-treatment resulted in a higher bacterial translocation to the mesenteric lymph  
nodes and lungs, and to a lesser extent to liver and spleen (Table A2) [56]. It was shown in vitro that 
DON increased the translocation of SEPEC over the intestinal epithelial cell monolayer (IPEC-1) 
(Table A1) [14]. 
Mycotoxins increase the calf susceptibility to shiga toxin or verotoxin-producing E. coli  
(STEC)-associated hemorrhagic enteritis. Recently, Baines et al. [57] showed that exposing calves of 
less than one month old to the combination of aflatoxin and fumonisins promoted STEC-associated 
hemorrhagic enteritis (Table A2) [57]. 
Feeding a FB1-contaminated diet to pigs negatively affects the mucosal immune response against 
an infection with enterotoxigenic E. coli (ETEC). Devriendt et al. [58] showed a prolonged intestinal 
infection of E. coli in pigs administered fumonisins for 10 consecutive days and subsequently 
challenged with E. coli (F4+ ETEC) (Table A2). Antigen-presenting cells (APCs) have an important 
role in the mucosal immune system by connecting the innate and adaptive immune response, through 
uptake of antigen in lamina propria, maturation and migration to GALT, and interaction with T cells. 
FB1 negatively affected the function of intestinal APCs by a reduced up-regulation of the major 
histocompatibility complex class II (MHC-II), cluster of differentiation (CD) 80/6 and IL-12p40 
cytokine gene expression [58]. This altered function of APCs could therefore influence the  
E. coli-induced adaptive immune response [58,59]. Additionally, moniliformin and FB1 delayed 
systemic E. coli (avian pathogenic E. coli, APEC) clearance in broilers and turkeys after intravenous 
administration (Table A2) [60,61]. 
The results of these studies may also be valid for human infections since the gastro-intestinal tract 
of pigs and humans are very similar [58]. Infant diarrhea caused by enteropathogenic E. coli (EPEC) is 
known to be of major concern in developing countries and, for instance, enterohemorrhagic  
E. coli (EHEC) infections are a major worldwide public health hazard. 
3.3. Necrotic Enteritis in Broilers 
Necrotic enteritis (NE) is a disease in broilers caused by Clostridium perfringens. This Gram-positive 
spore-forming bacterium occurs naturally in the environment, feed and gastrointestinal tract of chickens 
and other animals [62,63]. NE is a complex, multifactorial enteric disease with many known and 
unknown factors influencing its occurrence and the severity of the outbreaks. The best-known 
predisposing factor is mucosal damage caused by coccidial pathogens [64]. Only C. perfringens strains 
expressing the NetB toxin are capable of inducing NE in broilers [65]. C. perfringens is auxotrophic 
for several amino acids, thus availability of these amino acids would allow extensive bacterial 
proliferation [63]. 
The intake of DON-contaminated feed is a predisposing factor for the development of necrotic 
enteritis in broiler chickens due to the negative influence on the epithelial barrier, and to an increased 
intestinal nutrient availability for clostridial proliferation. Recently, we [66] showed in an experimental 
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subclinical NE infection model that chickens fed a diet contaminated with DON for three weeks were 
more prone to develop NE lesions compared to chickens on a control diet (Table A2). The negative 
effects of DON on the small intestinal barrier can lead to an impaired nutrient digestion and leakage of 
plasma amino acids into the intestinal lumen, providing the necessary growth substrate for extensive 
proliferation of C. perfringens [66]. 
3.4. Edwardsiella ictaluri Infection in Catfish 
Edwardsiella ictaluri is a Gram-negative bacterium of the Enterobacteriaceae family. Bacillary 
Necrosis of Pangasianodon (BNP) caused by E. ictaluri is the most frequently occurring infectious 
disease in catfish [67]. Besides the Vietnamese freshwater production, also the American channel 
catfish (Ictalurus punctatus) industry suffers massively from E. icatluri infections which have been 
termed Enteric Septicemia of Catfish (ESC). BNP is characterized by multifocal irregular white spots 
of varying sizes on several organs including liver, spleen and kidney [68]. ESC in channel catfish may 
occur in an acute form characterized by enteritis and septicemia with rapid mortality, or in a chronic 
form, which is characterized by meningoencephalitis, open lesions on the cranial region and 
exophthalmia [69]. Mortality associated with the co-occurrence of Fusarium mycotoxins and E. ictaluri 
is difficult to predict in juvenile channel catfish. T-2 increased E. ictaluri-associated mortality [70], 
while moderate contamination of DON improved the survival of the channel catfish [71] (Table A2). 
Mycotoxin sensitivity differs between fish species. Rainbow trout, for example, are extremely sensitive 
to DON, while channel catfish are rather resistant [71,72]. Important data concerning the toxicity of 
the mycotoxin on the bacterium are lacking. Further investigation of the interaction between Fusarium 
mycotoxins and E. ictaluri will be necessary to evaluate the outcome. 
3.5. Swine Respiratory Disease 
Respiratory disease in pigs is often caused by the combined effects of multiple pathogens and 
predisposing factors [73]. Primary infections with bacteria such as Actinobacillus pleuropneumoniae, 
Mycoplasma hyopneumoniae, Bordetella bronchiseptica or viruses such as influenza virus and Porcine 
Reproductive and Respiratory Syndrome Virus (PRRSV), can predispose pigs to secondary pathogens 
such as Pasteurella multocida and Trueperella pyogenes [74]. Respiratory symptoms can vary 
depending on the pathogens involved. M. hyopneumoniae is the principal etiological agent responsible 
for enzootic pneumonia in pigs [75]. M. hyopneumoniae is an obligate symbiotic and host-specific 
bacterium, which is lacking a cell wall. This pathogen affects the respiratory mucosal clearance system 
by disrupting the celia on the epithelial surface and modulates the immune system of the respiratory 
tract. Consequently, M. hyopneumoniae predisposes animals to concurrent infections with other 
respiratory pathogens [75]. Dietary exposure to fumonisins induces pulmonary edema and may 
facilitate M. hyopneumoniae infection (Table A2) [76]. 
The progressive form of porcine atrophic rhinitis is often due to a combined infection with  
B. bronchiseptica and toxigenic P. multocida [73,77]. Dietary exposure to FB1 of piglets infected with 
both bacteria increases the risk of pneumonia and the severity of the pathological changes [73].  
P. multocida type A is the most frequently occurring secondary pathogen that can cause pneumonic 
pasteurellosis [78]. Halloy et al. [74] showed that inoculation of piglets with P. multocida combined 
with an oral bolus of FB1 induced a cough and a lung inflammatory process characterized by an 
increased number of total cells, macrophages and lymphocytes in broncheo-alveolar lavage fluid 
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(BALF). Lung lesions were more severe in these animals and consisted of subacute interstitial 
pneumonia [74]. 
4. Effect of Fusarium Toxins on Fungal Diseases 
Aspergillosis 
Aspergillus fumigatus is an ubiquitous saprophytic fungus found in soil, plant debris, and the indoor 
environment, including hospitals. This fungus is also an opportunistic pathogen. Inhalation of its 
conidia can cause life-threatening infections in the respiratory system of immunocompromised animals 
and humans. Respiratory macrophages are the first line of defense against inhaled Aspergillus conidia. 
T-2 impaired the phagocytotic activities of macrophages against A. fumigatus conidia in chickens and 
rabbits (Tables A1 and A2) [79,80]. However, the pro-inflammatory response of A. fumigatus infected 
chicken macrophages was increased by T-2 (Table A1) [80]. The effect of T-2 on the innate immune 
response against Aspergillus conidia is dual, which suggests that depending on the characteristics of 
the mycotoxin exposure and the animal, one of these effects will determine the outcome of this interaction. 
5. Effect of Fusarium Toxins on Viral Diseases 
5.1. Reovirus 
Reovirus is a non-enveloped double-stranded RNA virus that has been isolated from the  
gastro-intestinal tract and respiratory tract of both humans and animals [81,82]. Enteric reoviruses 
cause mostly a mild and self-limiting infection [82]. Nevertheless, reovirus infections can be more 
severe, affecting, for example, the central nervous system in mice and rats [81]. Viral arthritis is the 
most frequent reovirus-associated disease in poultry, which is characterized by lameness and swellings 
affecting primarily tarsometatarsal joints and the feet [83–85]. 
Fusarium mycotoxins negatively affect the intestinal virus clearance in mice. Li et al. [82,86] 
showed that high concentrations of DON and T-2 suppress the host immune response to reovirus as 
evidenced by the inability to clear the virus from the intestine as well as by increased fecal shedding of 
the virus (Table A2). Trichothecene exposure increased the intestinal viral load, which could increase 
inflammation and discomfort to the host during the infection process. The increased fecal shedding 
could enhance virus dissemination among individuals [86]. Both mycotoxins decreased the cell-mediated 
viral clearance by suppressing the gene expression of IFN-γ in Peyer’s Patches (PP) [82,86]. DON 
enhanced Th2 cytokine expression prior to and after reovirus infection, which potentiates the IgA and 
IgG responses to reovirus [82]. In contrast, T-2 suppressed reovirus-induced immunoglobulin 
responses [86]. The lack of a similar effect of Th2 cytokines by T-2 suggests inherent differences 
between both mycotoxins in their capacity to modulate cytokines during viral infection, although both 
mycotoxins belong to the class of trichothecenes [86]. Nevertheless, the intestinal clearance of reovirus 
was less efficient after T-2 exposure compared to DON [86]. Since reovirus infection in mice is used 
as a model for several enteric and respiratory viral infections in humans and other animals [81], these 
results could assume an impact of mycotoxins on host susceptibility to more virulent viruses. 
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5.2. Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) 
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is an enveloped single-stranded 
RNA virus belonging to the family Arteriviridae, within the order Nidovirales [87]. Currently, PRRS 
is one of the most economic significant diseases in swine production [87,88]. The clinical symptoms, 
respiratory or reproductive, vary with the viral strain, the immune status of the herd, and management 
factors [88,89]. PRRSV is a highly infectious virus that replicates within the monocytes or macrophages 
with the lung being a predominant site of viral multiplication [89]. Exposure of piglets to FB1 
increased the risk for PRRSV disease [90]. More severe histopathological lesions were observed when 
pigs were exposed to FB1 and subsequently inoculated with PRRSV. The authors suggest that FB1 
causes immunosuppression, facilitating PRRSV to induce more severe lesions [89]. Given the 
importance of PRRSV in worldwide swine production and the frequent occurrence of fumonisins, 
research should be performed investigating this interaction also at lower doses of FB1. 
6. Discussion 
In recent years, research investigating the effects of Fusarium mycotoxins on the intestinal and 
immune functions has made substantial progress. However, only limited information is available on 
the interaction between mycotoxins and infectious diseases. The aforementioned literature data 
indicates that Fusarium mycotoxins may influence the animal and human host susceptibility to enteric, 
systemic and respiratory infectious diseases. Depending on host, pathogen and mycotoxin characteristics, 
exposure to Fusarium mycotoxins can generally exacerbate infectious diseases. On the other hand, T-2 
has been shown to decrease the colonization capacity of Salmonella in the pig intestine. Fusarium 
mycotoxins may influence the host–pathogen interaction by negatively affecting the intestinal barrier 
function and the innate and adaptive immune response [9,23,26]. Fusarium mycotoxins affect the 
morphology and the barrier function of the intestinal layer [9], leading to increased translocation of 
different bacterial species including Salmonella enterica and E. coli, to the systemic compartment. The 
negative influence of these mycotoxins on the function of macrophages results in impaired 
phagocytosis of bacterial and fungal pathogens. However, also the adaptive immune response is 
targeted, demonstrated by the effect on gene expression of several cytokines, leading to an altered Th1 
and Th2 response. 
The economic impact of mycotoxins on animal production is generally considered to be mainly due 
to losses related to direct effects on animal health and trade losses related to grain rejection [91]. It is 
clear, however, that the indirect influence of myocotoxins on animal health, by enhancing infectious 
diseases, should also be taken into account. These effects, as reviewed here, occur even at low to 
moderate mycotoxin contamination levels of feed [8]. Some publications showed that these effects can 
even occur at contamination levels below the European guidance levels, suggesting that the legislation 
may not cover all deleterious health effects of mycotoxins. 
Fusarium mycotoxins have various acute and chronic effects on humans [92]. DON could play a 
role in diseases such as inflammatory bowel disease (IBD) [20,93]. Taken into account conditions such 
as environmental, socio-economic and food production, it seems plausible that the risk for  
food-associated mycotoxin exposure is even higher in developing countries [94]. Besides the risk for 
acute mycotoxicosis in developing countries [95], results obtained in animals suggest that low to 
moderate concentrations of these mycotoxins could also influence human susceptibility to  
infectious diseases. 
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The effect of multi-mycotoxin contamination and of less well-known or emerging mycotoxins on 
the human or animal susceptibility to infectious diseases is rather unknown. Multi-mycotoxin 
contamination of feed is frequently occurring, raising the question on the impact on animal toxicity of 
this phenomenon [3]. Several in vitro and in vivo studies demonstrated an enhanced toxicity and more 
severe immune suppression compared to single mycotoxin contamination [96–98]. In addition, plant 
metabolites of mycotoxins may also be present in feed and are known as masked mycotoxins [99]. 
Fusarium fungi and infected plants may produce conjugated forms of, for instance, DON, such as  
3-AcDON (3-acetylDON), 15-AcDON and DON-3G (DON-3-glucoside). Furthermore, mycotoxins 
can also be conjugated by certain food-processing techniques. These conjugated forms could have a 
direct toxic effect, or may be hydrolyzed to their precursor mycotoxin in the digestive tract of animals, 
resulting in higher exposure levels [100–102]. The influence of mycotoxin co-occurrence and masked 
mycotoxins on human and animal susceptibility to infectious diseases will be an important research 
question in the future. 
Global warming and increasing world population of humans are further important issues. Climate 
changes may affect the global distribution of mycotoxigenic fungi and their mycotoxins [103,104], but 
also the distribution of infectious diseases [105]. Livestock farming will remain an important component 
of the global food supply in the future. Animal health, including the impact of mycotoxins and 
susceptibility to infectious diseases, will be important future topics to produce enough safe food for the 
entire human population. 
In conclusion, Fusarium mycotoxins may alter the human and animal susceptibility to infectious 
diseases by affecting the intestinal health and the innate and adaptive immune system. Further research 
will be necessary to investigate the impact of mycotoxins on infectious diseases and to develop 
practical, economically justified, solutions to counteract mycotoxin contamination of feed and food, 
and its effects on human and animal health. 
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Table A1. Interaction between Fusarium mycotoxins and infectious diseases: in vitro approach. 
Mycotoxin  Exposure dose Exposure period Cell line (host species) Pathogen  Effect Reference(s) 
DON or T-2 >25 ng DON/mL or 5 ng T-2/mL;  ≥0.75 µg DON/mL or ≥2.5 ng T-2/mL 24 h 
undifferentiated IPEC1-J2; 
differentiated IPEC1-J2; (pig) Salmonella Typhimurium ↑ invasion [27,28] 
DON or T-2 0.5 µg DON/mL or ≥1.0 ng T-2/mL 24 h differentiated IPEC1-J2 (pig) Salmonella Typhimurium ↑ translocation [27,28] 
DON or T-2 0.025 µg DON/mL or 1 ng T-2/mL 24 h PAM2 (pig) Salmonella Typhimurium ↑ invasion [28,41] 
DON 5–50 µM (1.5–15 µg/mL) 48 h IPEC1-J1 (pig) E. coli (SEPEC)3 ↑ translocation [14] 
T-2 0.001 µM 6 h peritoneal macrophages (mouse) P. aeruginosa 4 ↓ phagocytosis [48] 
T-2 0.01−0.05 µM 20 h alveolar macrophages (rat) S. cerevisiae 5  ↓ phagocytosis [106] 
T-2 0.1 µM  6 h alveolar macrophages (rat) S. aureus 6 ↓ phagocytosis [106] 
T-2 1–5 ng/mL; 2–5 ng/mL 24 h HD-11 cell line8 (chicken) A. fumigatus 7 
↓ phagocytosis;  
↑ immune response(A); 
↑ germination 
[80] 
DON = deoxynivalenol; T-2=T-2 toxin; 1 IPEC = Intestinal Porcine Epithelial Cell; 2 PAM = porcine alveolar macrophage; 3 septicemic Escherichia coli; 4 Pseudomonas aeruginosa; 5 Saccharomyces cerevisae;  
6 Staphylococcus aureus; 7 Aspergillus fumigatus; 8 chicken macrophages; (A) = increased gene expression of IL-1β, IL-6, CCLi1, CXCLi1, CXCLi2, IL-18 and IL-12β. 
Table A2. The influence of Fusarium mycotoxins on infectious diseases in animals: in vivo approach. 
Mycotoxin Exposure dose Exposure period 
Animal 
species Age Pathogen Effect: compared to negative control Reference(s) 
DON,  
15-acetylDON,  
ZEN and fumonisins 
6.5 mg DON, 0.44 mg  
15-acetylDON, 0.59 mg ZEN and 
0.37 mg fumonisins/kg feed 
6 weeks chicken (broiler) 1 day E. maxima 
1  ↓ percentage of CD4+ and CD8+ T cells in jejunal mucosa [35] 
DON, 15-acetylDON 
and ZEN 
3.8 mg DON and 0.3 mg  
15-acetylDON and 0.2 mg 
ZEN/kg feed 
10 weeks chicken (broiler) 1 day 
E. acervulina 1,  
E. maxima 1,  
E. tenella 1  
↓ level of blood monocytes at end of challenge period; 
percentage of CD8+ T-cells not restored at end of recovery 




3.8 mg DON, 0.3 mg  
15-acetylDON and  
0.2 mg ZEN/kg feed 
10 weeks chicken (broiler) 1 day 
E. acervulina 1,  
E. maxima 1,  
E. tenella 1  
↓ intestinal recovery: duodenal villus height and apparent 
villus surface area [36] 
DON 1 µg/mL 6 h pig 5 weeks Salmonella Typhimurium synergistic ↑ gene expression IL-12, TNF-α, IL-1β, IL-8, MCP-1 and IL-6 [27] 
T-2 15 and 83 µg/kg feed 23 days pig 3 weeks Salmonella Typhimurium  ↓ colonization of the cecum [28] 
FB1 and FB2 8.6 mg FB1 and 3.2 mg FB2/kg feed 9 weeks pig 4 weeks Salmonella Typhimurium  synergistic transient effect digestive microbiota balance [42] 
T-2 2 mg/kg BW 2 days chicken (broiler) 1 day Salmonella Typhimurium  ↑ mortality [45] 
T-2 1 mg/kg BW 3 weeks mouse 5–6 weeks Salmonella Typhimurium  ↑ mortality [46] 
T-2 1 mg/kg BW 10 days mouse 5–6 weeks Salmonella Typhimurium  ↑ bacteria-related organ lesions [47] 
T-2 2 mg/kg BW s.a. mouse - Salmonella Typhimurium ↑ mortality [48] 
DON 1 mg/L drinking water 3 weeks mouse 7 weeks Salmonella Enteritidis ↑ translocation to mesenteric lymph node, liver and spleen [51] 
FB1 150 mg/kg feed 6 weeks Japanese quail 1 day Salmonella Gallinarum 
↑ clinical signs and mortality;  
↓ blood lymhocyte number [107] 
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Table A2. Cont. 
Mycotoxin Exposure dose Exposure period 
Animal 
species Age Pathogen Effect: compared to negative control Reference(s) 
FB1 0.5 mg/kg BW  6 days pig 3 weeks E. coli (SEPEC) 2 
↑ intestinal colonization;  
↑ translocation to the mesenteric lymph node, lung, liver and 
spleen 
[56] 
FB1 1 mg/kg BW 10 days pig 3–4 weeks E. coli (ETEC) 3 intestinal infection prolonged; impaired function of intestinal antigen presenting cells [58] 
fumonisins  
and aflatoxin 
a 50–350 ng fumonisins /mL and 
1–3 ng aflatoxin/mL – calf <1 month E. coli (STEC) 
4 ↑ susceptibility to hemorrhagic enteritis  [57] 
moniliformin 75–100 mg/kg feed 3 weeks chicken (broiler) 0 day E. coli (APEC) 
5 ↓ bacterial clearance  [60] 
moniliformin  
and FB1 
100 mg moniliformin and 200 mg 
FB1/kg feed 3 weeks turkey 0 day E. coli 
3 (APEC) 5 ↓ bacterial clearance  [61] 
DON 4–5 mg/kg feed 3 weeks chicken (broiler) 1 day C. perfringens 
6 ↑ number of chickens with necrotic enteritis [66] 
DON 5–10 mg/kg feed 10 weeks channel catfish juvenile E. ictaluri 
7 ↓ mortality [71] 
T-2 1–2 mg/kg 6 weeks channel catfish juvenile E. ictaluri 
7 ↑ mortality [70] 
FB1, FB2 and FB3 20 mg FB1, 3.5 mg FB2 and 1.9 mg FB3/kg feed 42 days pig 3 days M. hyopneumoniae 
8 ↑ severity of the pathological changes [76] 
FB1 10 mg/kg feed 24 days pig 3 days B. bronchiseptica 
9 and P. 
multocida 10 (type D) ↑ extent and severity of the pathological changes [73] 
FB1 0.5 mg/kg BW 7 days pig piglets P. multocida 10 (type A) 
↓ growth rate and ↑ coughing; ↑ total number of cells, 
number of macrophages and lymphocytes in BALF; ↑ gross 
pathological lesions and histopathological lesion of lungs 
[74] 
T-2 mg/mouse ≈ 3.3 mg/kg BW 20 days mouse adult M. tuberculosis 
11 
(H37RvR-KM) ↑ bacterial count in spleen [108] 
T-2 0.1 mg/mouse   ≈ 3.3 mg/kg BW 20 days
 mouse adult M. bovis 12 ↓ mouse survival time [108] 
T-2 0.5 mg/kg BW 21 days rabbit – A. fumigatus 13 ↓ phagocytosis by alveolar macrophages [79] 
T-2 2 mg/kg BW s.a. mouse – P. aeruginosa 14 ↓ phagocytosis by peritoneal macrophages [48] 
DON 25 mg/kg BW s.a. mouse 7–10 weeks reovirus (serotype 1) 
↓ viral clearance and ↑ fecal shedding 
↓ Th1 response by ↓ IFN-γ gene expression 
↑ intestinal IgA and ↑ Th 2 response: by ↑ IL-4, IL-6 and  
IL-10 gene expression 
[82] 
T-2 1.75 mg/kg BW s.a. mouse 7–10 weeks reovirus (serotype 1) ↓ viral clearance and ↑ fecal shedding;  ↓ Th1 response by ↓ IFN-γ gene expression [86] 
FB1 12 mg/kg BW 18 days pig 1 month PRRSV15 ↑ histopathological lesions of lungs [89] 
DON = deoxynivalenol; T-2 = T-2 toxin; ZEN = zearalenone; FB1 = fumonisin B1; FB2 = fumonisin B2; FB3 = fumonisin B3; BW = bodyweight; a mycotoxin level detected in the hemorrhaged mucosa;  s.a. = single 
administration; 1 Eimeria; 2 septicemic Escherichia coli; 3 enterotoxigenic Escherichia coli; 4 shiga toxin producing Escherichia coli; 5 avian pathogenic Escherichia coli; 6 Clostridium perfringens; 7 Edwardsiella 
ictaluri; 8 Mycoplasma hyopneumoniae; 9Bordetella bronchiseptica; 10 Pasteurella multocida; 11 Mycobacterium tuberculosis; 12 Mycobacterium bovis; 13 Aspergillus fumigatus; 14 Pseudomonas aeroginosa;  
15 PRRSV = Porcine Reproductive and Respiratory Syndrome Virus. 
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Table A3. European Union limits for foodstuffs for human consumption, feed material and finished feed for animals adapted from the 
European Commission Regulation No 1881/2006 [109] and the European Commission Recommendations 2006/576/EC [110] and 
2013/165/EU [111] 
Mycotoxin Foodstuffs for human consumption/finished animal feed Maximum levels (µg/kg) 
DON 
unprocessed cereals other than durum wheat, oats and maize 1250 
unprocessed durum wheat and oats 1750 
unprocessed maize, with the exception of unprocessed maize intended to be processed by wet milling 1750 
cereals intended for direct human consumption, cereal flour, bran and germ as end product marketed for direct human consumption, with the exception of 
foodstuffs listed in (1). 750 
pasta (dry) 750 
bread (including small bakery wares), pastries, biscuits, cereal snacks and breakfast cereals 500 
(1) processed cereal-based foods and baby foods for infants and young children 200 
feed materials:  
cereals and cereal products with the exception of maize by-products 8000 
maize by-products 12,000 
complementary and complete feedingstuffs:  
all animal species with the exception of (2) 5000 
(2) complementary and complete feedingstuffs for pigs 900 
(2) complementary and complete feedingstuffs for calves (<4 months), lambs and kids 2000 
ZEN 
unprocessed cereals other than maize 100 
unprocessed maize with the exception of unprocessed maize intended to be processed by wet milling 350 
cereals intended for direct human consumption, cereal flour, bran and germ as end product marketed for direct human consumption, with the exception of 
foodstuffs listed in (2) 75 
refined maize oil 400 
bread (including small bakery wares), pastries, biscuits, cereal snacks and breakfast cereals, excluding maize snacks and maize-based breakfast cereals 50 
(2) maize intended for direct human consumption, maize-based snacks and  
maize-bases breakfast cereals 100 
(2) processed cereal-based foods (excluding processed maize-based foods) and baby foods for infants and young children 20 
(2) processed maize-based foods for infants and young children  20 
feed materials:  
cereals and cereal products with the exception of maize by-products 2000 
maize by-products 3000 
complementary and complete feedingstuffs:  
complementary and complete feedingstuffs for piglets and gilts (young sows) 100 
complementary and complete feedingstuffs for sows and fattening pigs  
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Table A3. Cont. 
Mycotoxin Foodstuffs for human consumption/finished animal feed Maximum levels (µg/kg) 
Fumonisins  
(sum FB1 + 
FB2) 
unprocessed maize with the exception of unprocessed maize intended to be processed by wet milling 4000 
maize intended for direct human consumption, maize-based foods for direct human consumption, with the exception of foodstuffs listed in (3) 1000 
(3) maize-based breakfast cereals and maize-based snacks 800 
(3) processed maize-based foods and baby foods for infants and young children 200 
feed materials:  
maize and maize products 60,000 
complementary and complete feedingstuffs:  
complementary and complete feedingstuffs for pigs, horses (Equidae), rabbits and pet animals 5000 
complementary and complete feedingstuffs for  fish 10,000 
complementary and complete feedingstuffs for poultry, calves (<4 months), lambs and kids 20,000 
complementary and complete feedingstuffs for adult ruminants (>4 months) and mink 50,000 
Sum T-2  
and HT-2 
unprocessed cereals:  
barley (including malting barley) and maize 200 
oats (with husk) 1000 
wheat, rye and other cereals  100 
cereal grains for direct human consumption:  
oats 200 
maize 100 
other cereals 50 
cereal products for human consumption:  
oat bran and flaked oats 200 
cereal bran except oat bran, oat milling products other than oat bran and flaked oats, and maize milling products 100 
other cereal milling products 50 
breakfast cereals including formed cereal flakes 75 
bread (including small bakery wares), pastries, biscuits, cereal snacks, pasta 25 
cereal-based foods for infants and young children 15 
cereal products for feed:  
oat milling products (husks) 2000 
other cereal products 500 
compound feed:  
compound feed, with the exception of feed for cats 250 
(DON = deoxynivalenol, ZEN= zearalenone, T-2= T-2 toxin, HT-2= HT-2 toxin, FB1 = fumonisin B1, FB2 = fumonisin B2) 
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